|
News Release |
1001
Connecticut Ave, NW - Ste 710 - Washington, DC 20036 |
July 20, 2000
Medical Marijuana Clubs In California Can Legally Distribute To Some Patients
Oakland, CA:
U.S. District Court Judge Charles Breyer
modified a 1998
injunction this Monday against the Oakland Cannabis Buyers' Cooperative
that will now allow the group to legally distribute marijuana to
seriously ill patients who qualify for a medical necessity defense.
Last September, the U.S. 9th Circuit Court of Appeals ordered Breyer to
reconsider his injunction against the OCBC and consider "the criteria for
a medical necessity exemption," under federal law. The following month,
the U.S. Justice Department asked the 9th Circuit to reconsider that
decision, and the court refused.
"The government continues to press arguments which the 9th Circuit
rejected, including the argument that the court must find that enjoining
the distribution of cannabis to seriously ill individuals is in the
public interest because Congress has prohibited such conduct in favor of
the administrative process regulating the approval and distribution of
drugs," Breyer wrote in modifying his injunction. "As a result of the
government's failure to offer any new evidence in opposition to
defendants' motion, and in light of the Ninth Circuit's opinion, the
Court must conclude that modifying the injunction as requested is in the
public interest and exercise its equitable discretion to do so."
"We applaud the wisdom of the judicial branch of government which now
recognizes what the citizens of every state already know, that sick
patients should have legal access to the medicine they need," said Robert
Raich, Esq., attorney for the Oakland Cannabis Buyers' Cooperative.
NORML Executive Director Keith Stroup said it is important that patients
in California understand that the criteria required to qualify for the
medical necessity defense in federal court are different from, and far
more difficult to meet, than the requirements of Proposition 215.
"Many patients protected from state prosecution by Proposition 215 will
still be vulnerable to a misguided federal prosecutor who chooses to
initiate a federal prosecution," Stroup said. "Nonetheless, this is
still
a major victory for patients in California."
For more information, please contact Robert Raich, Esq., at (510)
338-0700 or Keith Stroup, NORML Executive Director at (202) 483-5500.
Research Demonstrates Marijuana Is Safe For HIV Patients
San Francisco, CA:
Researchers at the University of
California-San
Francisco have found that HIV patients who smoke marijuana do not disrupt
the effect of anti-retroviral drugs.
This was the first double blind study in the United States to examine
marijuana and HIV patients. Sixty-seven people participated in the study
that was conducted by Donald Abrams, MD at San Francisco General
Hospital. Twenty of the patients smoked marijuana three times a day and
gained an average of 7.7 pounds during the 21-day study; 25 patients took
oral dronabinol (synthetic THC) and gained on average 7 pounds; and 21
patients took the placebo and gained only 2.9 pounds on average.
Thirty-six of the patients started the study with undetectable HIV RNA
levels and those levels remained constant throughout the study. The 26
patients who had detectable HIV RNA levels experienced declines. The
patients who smoked marijuana or took oral dronabinol experienced
slightly greater decreases in HIV RNA levels than the patients who took
the placebo.
"The slightly better decline experienced by those using marijuana or
dronabinol is intriguing, but not statistically significant," Abrams
said. "The good news is that there is no statistical difference between
the three groups."
"The fact of the matter is that any good clinician with his eyes and
ears open has known for a long time that cannabis is very useful in the
treatment of the AIDS reduction syndrome and does not harm patients,"
said Professor Lester Grinspoon, MD, of the Harvard Medical School and
NORML Foundation Chair. "When all the dust settles, and when marijuana is
admitted to the U.S. pharmacopoeia, it will be seen as one of the least
toxic drugs in the whole compendium."
For more information, please contact Donald Abrams at (415) 476-9554
ext. 12; Allen St. Pierre, NORML Foundation Executive Director at (202)
483-8751; or Lester Grinspoon, MD, NORML Foundation Chair at (617)
277-8423.
San Francisco Issues Medical Marijuana ID Cards
San Francisco, CA:
Medical marijuana patients in San
Francisco can now
obtain identification cards from the city of San Francisco that allow for
easier access to marijuana and also protect them from marijuana arrests
under the state's medical marijuana law.
The new identification card program kicked off last Friday.
The card
costs $25 and can be obtained at the San Francisco Department of Public
Health. Patients need to provide a doctor's recommendation to receive the
card.
The cards will only have the patient's picture and a serial number on it
in order to protect the patient's privacy. The San Francisco Department
of Public Health will not maintain a list of patients' names or
application documents.
Wayne Justmann, director of the San Francisco Patients Resource Center
and the recipient of the first card issued under the new program, said
the cards are "another brick in the path paving the way to legal use of
medical marijuana."
"This card recognizes the right of every medical cannabis patient to use
cannabis in a safe and effective manner," said San Francisco Supervisor
Mark Leno who sponsored the ordinance that created the cards. "The police
need to understand this card deserves 100 percent respect."
For more information, please contact Wayne Justmann at (415) 552-8653.
- End -